|
Volumn 6, Issue , 2006, Pages
|
Nuclear medicine imaging and therapy of neuroendocrine tumours.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DIAGNOSTIC AGENT;
PEPTIDE;
RADIOPHARMACEUTICAL AGENT;
RECEPTOR;
ARTICLE;
BONE MARROW DISEASE;
CLINICAL TRIAL;
DRUG EFFECT;
FORECASTING;
HUMAN;
ISOTOPE LABELING;
KIDNEY DISEASE;
LIVER DISEASE;
METHODOLOGY;
NEOPLASM;
NEUROENDOCRINE TUMOR;
RADIATION INJURY;
RADIOIMMUNOASSAY;
RADIOIMMUNOTHERAPY;
SCINTISCANNING;
SENSITIVITY AND SPECIFICITY;
BONE MARROW DISEASES;
CLINICAL TRIALS;
FORECASTING;
HUMANS;
ISOTOPE LABELING;
KIDNEY DISEASES;
LIVER DISEASES;
NEOPLASMS;
NEUROENDOCRINE TUMORS;
PEPTIDES;
RADIATION INJURIES;
RADIOIMMUNODETECTION;
RADIOIMMUNOTHERAPY;
RADIOPHARMACEUTICALS;
RECEPTORS, PEPTIDE;
SENSITIVITY AND SPECIFICITY;
|
EID: 37749024444
PISSN: None
EISSN: 14707330
Source Type: Journal
DOI: 10.1102/1470-7330.2006.9038 Document Type: Article |
Times cited : (13)
|
References (0)
|